Search

Your search keyword '"Schreiber, Taylor H."' showing total 40 results

Search Constraints

Start Over You searched for: Author "Schreiber, Taylor H." Remove constraint Author: "Schreiber, Taylor H." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
40 results on '"Schreiber, Taylor H."'

Search Results

1. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

2. Lipid-encapsulated mRNAs encoding complex fusion proteins potentiate anti-tumor immune responses

4. Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

5. Abstract 1815: Rapid serial killing of target cells by Vγ9Vδ2 T Cells in cynomolgus macaques and humanized mice treated with a CD20-directed heterodimeric butyrophilin 2A1/3A1 fusion protein

7. Abstract 4214: LIGHT (TNFSF14) costimulation with TIGIT blockade broadens the activity of checkpoint inhibitors (CPIs) into CPI refractory and resistant tumors through targeted myeloid cell and effector lymphocyte activation

8. Abstract 3514: Bispecific gamma delta T cell engagers containing butyrophilin 2A1/3A1 heterodimeric fusion protein efficiently activate Vg9Vd2 T cells and promote tumor cell killing

9. Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection

13. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

14. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation

19. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

20. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

28. Response to Taraban, Ferdinans, and, and Al-Shamkani

36. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016

37. Host CD4+CD25+T cells can expand and comprise a major component of the Treg compartment after experimental HCT

38. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

39. TNFRSF25 Agonistic Antibody and Galectin-9 Combination Therapy Controls Herpes Simplex Virus-Induced Immunoinflammatory Lesions.

40. Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses.

Catalog

Books, media, physical & digital resources